The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Peabody Robert since 2011.
The trader's CIK number is 1317296.
At the time of the last reporting, Peabody Robert was the Senior VP, COO & CFO of Lineage Cell Therapeutics, Inc.. (stock ticker symbol LCTX).
Also see all insider trading activities at Lineage Cell Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | BTX | 0 | $0 | 100,000 | $265,000 | 500,000 | $250,000 |
| 2011 | BTX | 5,400 | $24,040 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-07-21 | BTX | Option Ex | 475,000 | .50 | 237,500 |
| 2014-07-22 | BTX | Sale | 100,000 | 2.65 | 265,000 |
| 2014-01-06 | BTX | Option Ex | 25,000 | .50 | 12,500 |
| 2011-06-22 | BTX | Buy | 5,400 | 4.45 | 24,040 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Peabody Robert (Senior VP, COO & CFO of Lineage Cell Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.